GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Wiley  (2)
  • Higaki, Katsumi  (2)
  • 1
    In: Clinical and Translational Medicine, Wiley, Vol. 13, No. 8 ( 2023-08)
    Abstract: Niemann–Pick disease type C (NPC) is a fatal neurodegenerative disorder caused by abnormal intracellular cholesterol trafficking. Cyclodextrins (CDs), the most promising therapeutic candidates for NPC, but with concerns about ototoxicity, are cyclic oligosaccharides with dual functions of unesterified cholesterol (UC) shuttle and sink that catalytically enhance the bidirectional flux and net efflux of UC, respectively, between the cell membrane and the extracellular acceptors. However, the properties of CDs that regulate these functions and how they could be used to improve treatments for NPC are unclear. Methods We estimated CD–UC complexation for nine CD derivatives derived from native α‐, β‐, and γ‐CD with different cavity sizes, using solubility and molecular docking analyses. The stoichiometry and complexation ability of the resulting complexes were investigated in relation to the therapeutic effectiveness and toxicity of each CD derivative in NPC experimental models. Findings We found that shuttle and sink activities of CDs are dependent on cavity size‐dependent stoichiometry and substituent‐associated stability of CD–UC complexation. The ability of CD derivatives to form 1:1 and 2:1 complexes with UC were correlated with their ability to normalize intracellular cholesterol trafficking serving as shuttle and with their cytotoxicity associated with cellular UC efflux acting as sink, respectively, in NPC model cells. Notably, the ability of CD derivatives to form an inclusion complex with UC was responsible for not only efficacy but ototoxicity, while a representative derivative without this ability negligibly affected auditory function, underscoring its preventability. Conclusions Our findings highlight the importance of strategies for optimizing the molecular structure of CDs to overcome this functional dilemma in the treatment of NPC.
    Type of Medium: Online Resource
    ISSN: 2001-1326 , 2001-1326
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2697013-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: British Journal of Pharmacology, Wiley, Vol. 178, No. 13 ( 2021-07), p. 2727-2746
    Abstract: Niemann‐Pick disease type C (NPC) is a lysosomal storage disorder with disrupted intracellular cholesterol trafficking. A cyclic heptasaccharide, 2‐hydroxypropyl‐β‐cyclodextrin (HP‐β‐CD), is a cholesterol solubilizer that is being developed to treat NPC, but its ototoxicity and pulmonary toxicity remain important issues. We have characterized 2‐hydroxypropyl‐γ‐cyclodextrin (HP‐γ‐CD), a cyclic octasaccharide with a larger cavity than HP‐β‐CD, as a candidate drug to treat NPC. However, the molecular target of HP‐γ‐CD with respect to NPC and its potential for clinical application are still unclear. Experimental Approach We investigated the mode of interaction between HP‐γ‐CD and cholesterol by phase‐solubility analysis, proton NMR spectroscopy and molecular dynamics simulations. We then evaluated the therapeutic effects of HP‐γ‐CD compared with HP‐β‐CD using cellular and murine NPC models. Mouse auditory and pulmonary function tests were also conducted. Key Results HP‐γ‐CD solely formed a 1:1 inclusion complex with cholesterol with an affinity similar to that of HP‐β‐CD. In vitro, HP‐γ‐CD and HP‐β‐CD amelioration of NPC‐related manifestations was almost equivalent at lower concentrations. However, at higher concentrations, the cholesterol inclusion mode of HP‐β‐CD shifted to the highly soluble 2:1 complex whereas that of HP‐γ‐CD maintained solely the 1:1 complex. The constant lower cholesterol solubilizing ability of HP‐γ‐CD conferred it with significantly reduced toxicity compared with HP‐β‐CD, but equal efficacy in treating a mouse model of NPC. Conclusions and Implications HP‐γ‐CD can serve as a fine‐tuned cholesterol solubilizer for the treatment of NPC with a wider safety margin than HP‐β‐CD in terms of ototoxicity and pulmonary toxicity.
    Type of Medium: Online Resource
    ISSN: 0007-1188 , 1476-5381
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2021
    detail.hit.zdb_id: 2029728-2
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...